Archive for 2007
November 19, 2007
Immune system can drive cancers into dormant state
A multinational team of researchers, which includes LICR New York Branch Director, Dr. Lloyd J. Old, has shown for the first time that the immune system can stop the growth of a cancerous tumor without actually killing it.
November 4, 2007
Ludwig Institute for Cancer Research to set up its first Asian branch in Singapore
A memorandum of understanding (MOU) has been signed by the worlds largest international non-profit cancer research institute, the Ludwig Institute for Cancer Research (LICR), to establish a branch for translational and clinical cancer research in Singapore. This is in collaboration with three Singapore institutions, namely, the Agency for Science, Technology and Research (A*STAR), the Yong Loo Lin School of Medicine of the National University of Singapore (YLL-NUS) and the Duke-NUS Graduate Medical School (Duke-NUS GMS).
October 8, 2007
Webster K. Cavenee elected to Institute of Medicine
Dr. Webster Cavenee, Director of the LICR San Diego Branch, was today elected as a Member of the Institute of Medicine. Established in 1970 by the National Academy of Sciences, the Institute has become recognized as a national resource for independent, scientifically informed analysis and recommendations on human health issues.
June 14, 2007
Brazil’s first oncology biotech launches
Recepta, Brazil’s first oncology biotechnology company was launched today by PR&D, a Brazilian venture capital company, and the international non-profit Ludwig Institute for Cancer Research (LICR). The company will explore the therapeutic potential of three antibodies discovered and characterized by LICR.
June 5, 2007
Largest ever Phase III lung cancer trial based on LICR discovery
GSK has announced the launch of the largest ever Phase III trial in lung cancer treatment, which is based on the MAGE-A3 cancer-testis antigen discovered by the Ludwig Institute for Cancer Research. Results from a Phase II trial showed that the cancer vaccine, or ‘antigen-specific cancer immunotherapy (ASCI),’ showed a 27% reduction in the relative risk of recurrence of non-small cell lung cancer (NSCLC) following surgery.
April 17, 2007
Ludwig Institute for Cancer Research Investigators Scoop Cancer Research Awards
The American Association for Cancer Research (AACR) today awarded two of its top three prizes to investigators from the international Ludwig Institute for Cancer Research (LICR). The Kirk A. Landon-AACR Prize for Basic Cancer Research was awarded to Dr. Richard D. Kolodner, LICR Executive Director for Laboratory Science & Technology, and the inaugural The Princess Takamatsu Memorial Lectureship was awarded to Dr. Webster K. Cavenee, Director of the LICR San Diego Branch. The AACR is the largest and most prestigious professional association for cancer researchers with a membership of over 24,000 worldwide
March 13, 2007
Lloyd J. Old M.D., Director of the LICR New York Branch, awarded the 2007 Charles Rodolphe Brupbacher Cancer Research Award
Lloyd J. Old M.D., Director of the LICR New York Branch, was today awarded the 2007 Charles Rodolphe Brupbacher Cancer Research Award at a prize ceremony in Zurich, Switzerland. The Award, which is conferred every second year, honors internationally recognized cancer researchers. Dr. Old shared the award for contributions in the field of, ‘Cancer Immunosurveillance and Immunotherapy,’ with LICR Affiliate, Dr. Robert Schreiber (Washington University, St Louis, USA) and Dr. Mark Smyth (Peter MacCallum Cancer Centre, Melbourne, Australia).
March 6, 2007
Webster K. Cavenee Ph.D., Director of the San Diego Branch, awarded the 2nd Annual Albert Szent-Gyorgyi Prize for Progress in Cancer Research
Dr. Cavenee was today awarded the Prize by the National Foundation for Cancer Research in honor of his groundbreaking discoveries regarding the mechanisms of predisposition to human cancer. Dr. Cavenee’s research led to the first hard experimental evidence for the existence of tumor suppressor genes in humans.
February 4, 2007
Beyond the DNA: chemical signatures reveal genetic switches in the genome
Investigators from the Ludwig Institute for Cancer Research (LICR) and the University of California, San Diego (UCSD) have made a breakthrough in identifying functional elements in the human genome, according to a report published online today in Nature Genetics.
January 26, 2007
Potential solution to cetuximab-resistance in lung cancers
A joint study conducted by the Dana-Farber Cancer Institute, the Ludwig Institute for Cancer Research and the Ludwig Center at Dana-Farber/Harvard Medical School now suggests that antibodies binding a particular protein conformation, caused by hyperactivation, might have distinct therapeutic advantages over antibodies, like cetuximab, that bind to wild-type (normal) target proteins.
January 19, 2007
Prize for Progress in Cancer Research Awarded to Webster K. Cavenee, Ph.D.
(Bethesda, MD) — The National Foundation for Cancer Research (NFCR) announced today that Webster K. Cavenee, Ph.D., Director of the LICR San Digo Branch, has been awarded the 2nd Annual Albert Szent-Györgyi Prize for Progress in Cancer Research.